Porcine endothelial cells and iliac arteries transduced with AdenoIL-4 are intrinsically protected, through Akt activation, against immediate injury caused by human complement

Journal of Immunology

Volumn 177, Issue 10, 2006, Pages 7355-7363

  Black, Sylvester M ^a   Grehan, John F ^a   Rivard, Andrew L ^a   Benson, Barbara A ^a   Wahner, Andrea E ^a   Koch, Alisa E ^b   Levay Young, Brett K ^a   Dalmasso, Agustin P ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD59 ANTIGEN; COMPLEMENT; CYTOKINE; DECAY ACCELERATING FACTOR; INTERLEUKIN 13; INTERLEUKIN 4; MEMBRANE COFACTOR PROTEIN; PROTEIN KINASE B;

ADENOVIRUS VECTOR; ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTERY INJURY; ARTERY PERFUSION; ARTICLE; BLOOD; CELL ACTIVATION; CELL DAMAGE; COMPLEMENT ACTIVATION; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; ENZYME ACTIVATION; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; IL 4 GENE; ILIAC ARTERY; IN VITRO STUDY; ISCHEMIA; NONHUMAN; PRIMATE; PRIORITY JOURNAL; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SWINE; UPREGULATION; VASCULAR DISEASE; XENOTRANSPLANTATION;

EID: 33750840511     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.10.7355     Document Type: Article

References (45)

1. Cines, D. B., E. S. Pollak, C. A. Buck, J. Loscalzo, G. A. Zimmerman, R. P. McEver, J. S. Pober, T. M. Wick, B. A. Konkle, B. S. Schwartz, et al. 1998. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91: 3527-3561.
2. McGill, S. N., N. A. Ahmed, and N. V. Christou. 1998. Endothelial cells: role in infection and inflammation. World J. Surg. 22: 171-178.
3. Saadi, S., and J. L. Platt. 1998. Endothelial cell responses to complement activation. In: The Human Complement System in Health and Disease. S. E. Volanakis and M. M. Frank, eds. Dekker, New York, pp. 335-353.
4. Saadi, S., and J. L. Platt. 1995. Transient perturbation of endothelial integrity induced by natural antibodies and complement. J. Exp. Med. 181: 21-31.
5. Saadi, S., R. A. Holzknecht, C. P. Patte, D. M. Stern, and J. L. Platt. 1995. Complement-mediated regulation of tissue factor activity in endothelium. J. Exp. Med. 182: 1807-1814.
6. Dalmasso, A. P., G. M. Vercellotti, R. J. Fischel, R. M. Bolman, F. H. Bach, and J. L. Platt. 1992. Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. Am. J. Pathol. 140: 1157-1166.
7. Lin, S. S., B. C. Weidner, G. W. Byrne, L. E. Diamond, J. H. Lawson, C. W. Hoopes, L. J. Daniels, C. W. Daggett, W. Parker, R. C. Harland, et al. 1998. The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. J. Clin. Invest. 101: 1745-1756.
8. Paris, F., Z. Fuks, A. Kang, P. Capodieci, G. Juan, D. Ehleiter, A. Haimovitz-Friedman, C. Cordon-Cardo, and R. Kolesnick. 2001. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 293: 293-297.
9. Kim, I., H. G. Kim, J. N. So, J. H. Kim, H. J. Kwak, and G. Y. Koh. 2000. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Circ. Res. 86: 24-29.
10. Kim, H. H., H. S. Shin, H. J. Kwak, K. Y. Ahn, J. H. Kim, H. J. Lee, M. S. Lee, Z. H. Lee, and G. Y. Koh. 2003. RANKL regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. FASEB J. 17: 2163-2165.
11. Madge, L. A., and J. S. Pober. 2000. A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NF-κB in human endothelial cells. J. Biol. Chem. 275: 15458-15465.
12. Mahboubi, K., B. C. Biedermann, J. M. Carroll, and J. S. Pober. 2000. IL-11 activates human endothelial cells to resist immune-mediated injury. J. Immunol. 164: 3837-3846.
13. Evans, P. C., and P. J. Kilshaw. 2000. Interleukin-13 protects endothelial cells from apoptosis and activation: association with the protective genes A20 and A1. Transplantation 70: 928-934.
14. Bach, F. H., C. Ferran, P. Hechenleitner, W. Mark, N. Koyamada, T. Miyatake, H. Winkler, A. Badrichani, D. Candinas, and W. W. Hancock. 1997. Accommodation of vascularized xenografts: expression of "protective genes" by donor endothelial cells in a host TH2 cytokine environment. Nat. Med. 3: 196-204.
15. Grehan, J., B. Levay-Young, J. Fogelson, V. François- Bongarçon, B. Benson, and A. Dalmasso. 2005. IL-4 and IL-13 induce protection of porcine endothelial cells from killing by human complement and from apoptosis through activation of a phosphatidylinositide 3-kinase/Akt pathway. J. Immunol. 175: 1903-1910.
16. Dalmasso, A. P., B. A. Benson, J. S. Johnson, C. Lancto, and M. S. Abrahamsen. 2000. Resistance against the membrane attack complex of complement induced in porcine endothelial cells with a Gal α(1-3)Gal binding lectin: up-regulation of CD59 expression. J. Immunol. 164: 3764-3773.
17. Woods, J. M., K. J. Katschke, Jr., M. Tokuhira, H. Kurata, K. I. Arai, P. L. Campbell, and A. E. Koch. 2000. Reduction of inflammatory cytokines and prostaglandin E2 by IL-13 gene therapy in rheumatoid arthritis synovium. J. Immunol. 165: 2755-2763.
18. Woods, J. M., M. A. Amin, K. J. Katschke, Jr., M. V. Volin, J. H. Ruth, M. A. Connors, D. C. Woodruff, H. Kurata, K. Arai, G. K. Haines III, et al. 2002. Interleukin-13 gene therapy reduces inflammation, vascularization, and bony destruction in rat adjuvant-induced arthritis. Human Gene Ther. 13: 381-393.
19. Fujio, Y., and K. Walsh. 1999. Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner. J. Biol. Chem. 274: 16349-16354.
20. Morales-Ruiz, M., D. Fulton, G. Sowa, L. R. Languino, Y. Fujio, K. Walsh, and W. C. Sessa. 2000. Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt. Circulation Res. 86: 892-896.
21. Dalmasso, A. P., T. He, and B. A. Benson. 1996. Human IgM xenoreactive natural antibodies can induce resistance of porcine endothelial cells to complement-mediated injury. Xenotransplantation 3: 54-62.
22. Capey, S., and C. W. van den Berg. 2005. Porcine complement regulators protect aortic smooth muscle cells poorly against human complement-induced lysis and proliferation: consequences for Xenotransplantation. Xenotransplantation 12: 217-226.
23. Grubbs, B. C., B. A. Benson, and A. P. Dalmasso. 2003. Characteristics of CD59 up-regulation induced in porcine endothelial cells by α-Gal ligation and its association with protection from complement. Xenotransplantation 10: 387-397.
24. Kroshus, T. J., R. M. Bolman III, and A. P. Dalmasso. 1996. Selective IgM depletion prolongs organ survival in an ex vivo model of pig-to-human xenotransplantation. Transplantation 62: 5-12.
25. Schwertz, H., T. Langin, H. Platsch, J. Richert, S. Bomm, M. Schmidt, H. Hillen, G. Blaschke, J. Meyer, H. Darius, and M. Buerke. 2002. Two-dimensional analysis of myocardial protein expression following myocardial ischemia and reperfusion in rabbits. Proteomics 2: 988-995.
26. Ikari, N., Y. Sakai, Y. Hitomi, and S. Fujii. 1983. New synthetic inhibitor to the alternative complement pathway. Immunology 49: 685-691.
27. Rose, A. G. 1997. Histopathology of cardiac xenograft rejection. In Xenotransplantation. D. K. C. Cooper, E. Kemp, J. L. Platt, and D. J. G. White, eds. Springer, Berlin, pp. 255-272.
28. Fujio, Y., T. Nguyen, D. Wencker, R. N. Kitsis, and K. Walsh. 2000. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 101: 660-667.
29. Young, L. S., and V. Mautner. 2001. The promise and potential hazards of adenovirus gene therapy. Gut 48: 733-736.
30. Barbato, J. E., M. R. Kibbe, and E. Tzeng. 2003. The emerging role of gene therapy in the treatment of cardiovascular diseases. Crit. Rev. Clin. Lab. Sci. 40: 499-545.
31. Unger, G. M., A. T. Davis, J. W. Slaton, and K. Ahmed. 2004. Protein kinase CK2 as regulator of cell survival: implications for cancer therapy. Curr. Cancer Drug Targets 4: 77-84.
32. Smith, A., R. Collaco, and J. P. Trempe. 2004. AAV vector delivery to cells in culture. Methods Mol. Biol. 246: 167-177.
33. Chu, D., P. A. Thistlethwaite, C. C. Sullivan, M. S. Grifman, and M. D. Weitzman. 2004. Gene delivery to the mammalian heart using AAV vectors. Methods Mol. Biol. 246: 213-224.
34. Koch, C. A., A. Kanazawa, R. Nishitai, B. E. Knudsen, K. Ogata, T. B. Plummer, K. Butters, and J. L. Platt. 2005. Intrinsic resistance of hepatocytes to complement-mediated injury. J. Immunol. 174: 7302-7309.
35. Kraus, S., R. Seger, and Z. Fishelson. 2001. Involvement of the ERK mitogen-activated protein kinase in cell resistance to complement-mediated lysis. Clin. Exp. Immunol. 123: 366-374.
36. Aoudjit, L., M. Stanciu, H. Li, S. Lemay, and T. Takano. 2003. p38 mitogen-activated protein kinase protects glomerular epithelial cells from complement-mediated cell injury. Am. J. Physiol. 285: F765-F774.
37. Amaravadi, R., and C. B. Thompson. 2005. The survival kinases Akt and Pim as potential pharmacological targets. J. Clin. Invest. 115: 2618-2624.
38. Kelly-Welch, A. E., E. M. Hanson, M. R. Boothby, and A. D. Keegan. 2003. Interleukin-4 and interleukin-13 signaling connections maps. Science 300: 1527-1528.
39. Lai, L., D. Kolber-Simonds, K. W. Park, H. T. Cheong, J. L. Greenstein, G. S. Im, M. Samuel, A. Bonk, A. Rieke, B. N. Day, et al. 2002. Production of α-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 295: 1089-1092.
40. Dai, Y., T. D. Vaught, J. Boone, S. H. Chen, C. J. Phelps, S. Ball, J. A. Monahan, P. M. Jobst, K. J. McCreath, A. E. Lamborn, et al. 2002. Targeted disruption of the α1,3-galactosyltransferase gene in cloned pigs. Nat. Biotechnol. 20: 251-255.
41. McCurry, K. R., D. L. Kooyman, C. G. Alvarado, A. H. Cotterell, M. J. Martin, J. S. Logan, and J. L. Platt. 1995. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat. Med. 1: 423-427.
42. Lambrigts, D., D. H. Sachs, and D. K. Cooper. 1998. Discordant organ xenotransplantation in primates: world experience and current status. Transplantation 66: 547-561.
43. Zaidi, A., M. Schmoeckel, F. Bhatti, P. Waterworth, M. Tolan, E. Cozzi, G. Chavez, G. Langford, S. Thiru, J. Wallwork, et al. 1998. Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors. Transplantation 65: 1584-1590.
44. Chen, D., M. Weber, J. H. McVey, G. Kemball-Cook, E. G. Tuddenham, R. I. Lechler, and A. Dorling. 2004. Complete inhibition of acute humoral rejection using regulated expression of membrane-tethered anticoagulants on xenograft endothelium. Am. J. Transplant. 4: 1958-1963.
45. Lin, S. S., M. J. Hanaway, G. V. Gonzalez-Stawinski, C. L. Lau, W. Parker, R. D. Davis, G. W. Byrne, L. E. Diamond, J. S. Logan, and J. L. Platt. 2000. The role of anti-Galα1-3Gal antibodies in acute vascular rejection and accommodation of xenografts. Transplantation 70: 1667-1674.